ReP USP - Resultado da busca

Artigo de periodico
Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years (2015)
Lovell, Daniel J.; Ruperto, Nicolino; Mouy, Richard; Paz, Eliana; Rubio-Pérez, Nadina; Silva, Clovis A.; Abud-Mendoza, Carlos; Burgos-Vargas, Ruben; Gerloni, Valeria; Melo-Gomes, Jose A.; Saad-Magalhaes, Claudia; Chavez-Corrales, J.; Huemer, Christian; Kivitz, Alan; Blanco, Francisco J.; Foeldvari, Ivan; Hofer, Michael; Huppertz, Hans-Iko; Deslandre, Chantal Job; Minden, Kirsten; Punaro, Marilynn; Block, Alan J.; Giannini, Edward H.; Martini, Alberto
Source: Arthritis and Rheumatology. Unidade: FM
Subjects: DOENÇA CRÔNICA, MEDICAÇÃO INTRAVENOSA, QUALIDADE DE VIDA, ARTRITE REUMATÓIDE JUVENIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOVELL, Daniel J. et al. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Arthritis and Rheumatology, v. 67, n. 10, p. 2759-2770, 2015Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf. Acesso em: 25 jul. 2024.
APA
Lovell, D. J., Ruperto, N., Mouy, R., Paz, E., Rubio-Pérez, N., Silva, C. A., et al. (2015). Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Arthritis and Rheumatology, 67( 10), 2759-2770. doi:10.1002/art.39234
NLM
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz H-I, Deslandre CJ, Minden K, Punaro M, Block AJ, Giannini EH, Martini A. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years [Internet]. Arthritis and Rheumatology. 2015 ; 67( 10): 2759-2770.[citado 2024 jul. 25 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf
Vancouver
Lovell DJ, Ruperto N, Mouy R, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhaes C, Chavez-Corrales J, Huemer C, Kivitz A, Blanco FJ, Foeldvari I, Hofer M, Huppertz H-I, Deslandre CJ, Minden K, Punaro M, Block AJ, Giannini EH, Martini A. Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years [Internet]. Arthritis and Rheumatology. 2015 ; 67( 10): 2759-2770.[citado 2024 jul. 25 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/art.39234/pdf
Artigo de periodico
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial (2010)
Foell, Dirk; Wulffraat, Nico; Garay, Stella; Vojinovic, Jelena; Norambuena, Ximena; Gamir, María Luz; Consuegra, Julia García; Lepore, Loredana; Susic, Gordana; Corona, Fabrizia; Dolezalova, Pavla; Pistorio, Angela; Martini, Alberto; Ruperto, Nicolino; Roth, johannes; Wedderburn, Lucy R.; Wittkowski, Helmut; Frosch, Michael; Gerf, Joachim; Stanevicha, Valda; Mihaylova, Dimitrina; Ferriani, Virgínia Paes Leme; Tsakalidou, Florence Kanakoudi; Foeldvari, Ivan; Cuttica, Ruben; Gonzalez, Benito; Ravelli, Angelo; khubchandani, Raju; Oliveira, Sheila; Armbrust, Wineke
Source: JAMA: The Journal of the American Medical Association. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE JUVENIL, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOELL, Dirk et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association, v. 303, n. 13, p. 1266-1273, 2010Tradução . . Acesso em: 25 jul. 2024.
APA
Foell, D., Wulffraat, N., Garay, S., Vojinovic, J., Norambuena, X., Gamir, M. L., et al. (2010). Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association, 303( 13), 1266-1273.
NLM
Foell D, Wulffraat N, Garay S, Vojinovic J, Norambuena X, Gamir ML, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth johannes, Wedderburn LR, Wittkowski H, Frosch M, Gerf J, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, khubchandani R, Oliveira S, Armbrust W. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2010 ; 303( 13): 1266-1273.[citado 2024 jul. 25 ]
Vancouver
Foell D, Wulffraat N, Garay S, Vojinovic J, Norambuena X, Gamir ML, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth johannes, Wedderburn LR, Wittkowski H, Frosch M, Gerf J, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, khubchandani R, Oliveira S, Armbrust W. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA: The Journal of the American Medical Association. 2010 ; 303( 13): 1266-1273.[citado 2024 jul. 25 ]
Artigo de periodico
Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial (2010)
Vilca, Iris; Munitis, Pablo Garcia; Pistorio, Angela; Ravelli, Angelo; Buoncompagni, Antonella; Bica, Blanca; Campos, Lucia; Häfner, Renate; Hofer, Michael; Ozen, Seza; Huemer, Christian; Bae, Sang Cheol; Sztajnbok, Flavio; Arguedas, Olga; Foeldvari, Ivan; Huppertz, Hans Iko; Gamir, Maria Luz; Magnusson, Bo; Dressler, Frank; Uziel, Yosef; Rossum, Marion A. J. van; Hollingworth, Peter; Cawkwell, Gail; Martini, Alberto; Ruperto, Nicolino; Ferriani, Virgínia Paes Leme
Source: Annals of the Rheumatic Diseases. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE JUVENIL (TRATAMENTO), FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILCA, Iris et al. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Annals of the Rheumatic Diseases, v. 69, n. 8, p. 1479-1483, 2010Tradução . . Disponível em: https://doi.org/10.1136/ard.2009.120840. Acesso em: 25 jul. 2024.
APA
Vilca, I., Munitis, P. G., Pistorio, A., Ravelli, A., Buoncompagni, A., Bica, B., et al. (2010). Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Annals of the Rheumatic Diseases, 69( 8), 1479-1483. doi:10.1136/ard.2009.120840
NLM
Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, Campos L, Häfner R, Hofer M, Ozen S, Huemer C, Bae SC, Sztajnbok F, Arguedas O, Foeldvari I, Huppertz HI, Gamir ML, Magnusson B, Dressler F, Uziel Y, Rossum MAJ van, Hollingworth P, Cawkwell G, Martini A, Ruperto N, Ferriani VPL. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial [Internet]. Annals of the Rheumatic Diseases. 2010 ; 69( 8): 1479-1483.[citado 2024 jul. 25 ] Available from: https://doi.org/10.1136/ard.2009.120840
Vancouver
Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, Campos L, Häfner R, Hofer M, Ozen S, Huemer C, Bae SC, Sztajnbok F, Arguedas O, Foeldvari I, Huppertz HI, Gamir ML, Magnusson B, Dressler F, Uziel Y, Rossum MAJ van, Hollingworth P, Cawkwell G, Martini A, Ruperto N, Ferriani VPL. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial [Internet]. Annals of the Rheumatic Diseases. 2010 ; 69( 8): 1479-1483.[citado 2024 jul. 25 ] Available from: https://doi.org/10.1136/ard.2009.120840
Trabalho de evento-resumo periodico
A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission (2009)
Foell, David; Wulffraat, N.; Wedderburn, L. R.; Pistorio, Angela; Ravelli, Angelo; Stanevicha, Valda; Mihaylova, D.; Ferriani, Virgínia Paes Leme; Tsakalidou, F. Kanakoudi; Foeldvari, Ivan; Cuttica, R.; Gonzalez, B.; Khubchandani, R.; Oliveira, S. K. F.; Armbrust, W.; Garay, Stuart M.; Vojinovic, J.; Norambuena, X.; Gamir, M.; Consuegra, J. Garcia; Lepore, L.; Susic, G.; Corona, Fernando; Dolezalova, P.; Saurenmann, T.; Uziel, Y.; Martini, A.; Ruperto, Nicolino
Source: Annals of the Rheumatic Diseases. Conference titles: Annual European Congres of Rheumatology. Unidade: FMRP
Subjects: ARTRITE REUMATOIDE JUVENIL, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOELL, David et al. A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 25 jul. 2024. , 2009
APA
Foell, D., Wulffraat, N., Wedderburn, L. R., Pistorio, A., Ravelli, A., Stanevicha, V., et al. (2009). A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Foell D, Wulffraat N, Wedderburn LR, Pistorio A, Ravelli A, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Khubchandani R, Oliveira SKF, Armbrust W, Garay SM, Vojinovic J, Norambuena X, Gamir M, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Saurenmann T, Uziel Y, Martini A, Ruperto N. A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission. Annals of the Rheumatic Diseases. 2009 ; 68( suppl. 3): 307.[citado 2024 jul. 25 ]
Vancouver
Foell D, Wulffraat N, Wedderburn LR, Pistorio A, Ravelli A, Stanevicha V, Mihaylova D, Ferriani VPL, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Khubchandani R, Oliveira SKF, Armbrust W, Garay SM, Vojinovic J, Norambuena X, Gamir M, Consuegra JG, Lepore L, Susic G, Corona F, Dolezalova P, Saurenmann T, Uziel Y, Martini A, Ruperto N. A randomised trial of 6 months versus 12 months withdrawal of methotrexate in children with juvenile idiopathic arthritis in clinical remission. Annals of the Rheumatic Diseases. 2009 ; 68( suppl. 3): 307.[citado 2024 jul. 25 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation